title: Left ventricular diastolic filling changes during dipyridamole-induced ischaemia. An echo-Doppler study.
abstract: OBJECTIVE
  To evaluate the usefulness of the Doppler assessment of left ventricular diastolic functioning during dipyridamole-induced ischaemia in patients with coronary artery disease (CAD).
  
  
  METHODS
  We studied 28 patients with angiographically proven CAD [18 men, aged 62 +/- 7 years (mean +/- SD)] and 18 normal subjects (12 men, aged 59 +/- 7.5 years). Two-dimensional and transmitral flow Doppler echocardiography studies were performed at baseline and after intravenous administration of a high dose of dipyridamole (0.84 mg/kg during 10 min). Left ventricular wall motion was evaluated by two-dimensional Doppler echocardiography, with the left ventricle divided into a 16-segment model, whereas peak velocities of early and late diastolic flow, the early:late diastolic flow ratio and the deceleration rate of early diastolic flow were determined from transmitral flow Doppler echocardiography.
  
  
  RESULTS
  Sixteen patients developed new wall-motion abnormalities (WMA), whereas the remaining 12 patients and the controls did not. Multivariate logistic regression analysis was performed to identify which of the parameters had independent diagnostic value for revealing CAD. WMA was entered at the first step and yielded a 57% sensitivity and 100% specificity; the changes in deceleration rate were entered as the second step, which improved the sensitivity to 85.5%, and reduced the specificity to 83% and raised the overall accuracy to 85% from 70% for WMA alone. More specifically, the sensitivity improved from 37.5, 63.5 and 65.5% to 62.5, 91 and 100%, respectively, for patients with one-, two- and three-vessel disease. The cut-off value of the change in deceleration rate was 7%.
  
  
  CONCLUSIONS
  Patients could be classified as having CAD either if they developed new WMA or if the deceleration rate of early diastolic flow during dipyridamole-stress echocardiography increased by more than 7% compared with the rest value.
authors.affiliation: Cardiology Department, University Hospital of Heraklion, Crete, Greece.
authors.forename: F I
authors.initials: FI
authors.lastname: Parthenakis
authors.forename: K S
authors.initials: KS
authors.lastname: Karidis
authors.forename: G
authors.initials: G
authors.lastname: Zuridakis
authors.forename: E M
authors.initials: EM
authors.lastname: Kanoupakis
authors.forename: G I
authors.initials: GI
authors.lastname: Chlouverakis
authors.forename: P E
authors.initials: PE
authors.lastname: Vardas
mesh_terms: D016022:Case-Control Studies; D003327:Coronary Disease / Q000000981:diagnostic imaging* / Q000453:epidemiology; D003971:Diastole / Q000502:physiology; D004176:Dipyridamole; D004452:Echocardiography; D015150:Echocardiography, Doppler / Q000379:methods; D005260:Female; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000139:chemically induced / Q000000981:diagnostic imaging; D012680:Sensitivity and Specificity; D014665:Vasodilator Agents; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging*; D016277:Ventricular Function, Left / Q000502:physiology
chemical_list: D014665:Vasodilator Agents; D004176:Dipyridamole